Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083854 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Costanza Stacchiotti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neuroimmunology Unit, Santa Lucia Foundation, 00143 Rome, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Cytokines, Neuroinflammatory Diseases, Anti-Inflammatory Agents. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FISM-Fondazione Italiana Sclerosi Multipla.
Abstract (Originalsprache)
Neuroinflammation is an inflammatory response occurring within the central nervous system (CNS). The process is marked by the production of pro-inflammatory cytokines, chemokines, small-molecule messengers, and reactive oxygen species. Microglia and astrocytes are primarily involved in this process, while endothelial cells and infiltrating blood cells contribute to neuroinflammation when the blood–brain barrier (BBB) is damaged. Neuroinflammation is increasingly recognized as a pathological hallmark of several neurological diseases, including amyotrophic lateral sclerosis (ALS), and is closely linked to neurodegeneration, another key feature of ALS. In fact, neurodegeneration is a pathological trigger for inflammation, and neuroinflammation, in turn, contributes to motor neuron (MN) degeneration through the induction of synaptic dysfunction, neuronal death, and inhibition of neurogenesis. Importantly, resolution of acute inflammation is crucial for avoiding chronic inflammation and tissue destruction. Inflammatory processes are mediated by soluble factors known as cytokines, which are involved in both promoting and inhibiting inflammation. Cytokines with anti-inflammatory properties may exert protective roles in neuroinflammatory diseases, including ALS. In particular, interleukin (IL)-10, transforming growth factor (TGF)-β, IL-4, IL-13, and IL-9 have been shown to exert an anti-inflammatory role in the CNS. Other recently emerging immune regulatory cytokines in the CNS include IL-35, IL-25, IL-37, and IL-27. This review describes the current understanding of neuroinflammation in ALS and highlights recent advances in the role of anti-inflammatory cytokines within CNS with a particular focus on their potential therapeutic applications in ALS. Furthermore, we discuss current therapeutic strategies aimed at enhancing the anti-inflammatory response to modulate neuroinflammation in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Neuroimmunology Unit, Santa Lucia Foundation, 00143 Rome, Italy.
- Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
- Department of Biology and Biotechnology Charles Darwin, Sapienza University, 00185 Rome, Italy.
- Molecular Neurobiology Unit, Santa Lucia Foundation, 00143 Rome, Italy.
ORCID-Profile: Alida Spalloni, Elisabetta Volpe
Förderung
- FISM-Fondazione Italiana Sclerosi Multipla
Zitieren
APA
Stacchiotti, C., Mazzella di Regnella, S., Cinotti, M., Spalloni, A., & Volpe, E. (2025). Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083854
Vancouver
Stacchiotti C, Mazzella di Regnella S, Cinotti M, Spalloni A, Volpe E. Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083854
BibTeX
@article{Stacchiotti2025,
author = {Stacchiotti, Costanza and Mazzella di Regnella, Simona and Cinotti, Miriam and Spalloni, Alida and Volpe, Elisabetta},
title = {Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083854}
}
EUVIMED